Improving how well certain drugs are absorbed in the body
Novel Formulation Technology to Enhance Oral Absorption of Water-insoluble Drugs
This study is working on new ways to help people absorb certain medications better by using special ingredients and tiny particles, so that patients can get more effective treatment from their oral medicines.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-10728429 on NIH RePORTER |
What this research studies
This research focuses on developing new formulation technologies to enhance the oral absorption of water-insoluble drugs, which are often challenging to deliver effectively. The approach involves creating lipid-based drug delivery systems and exploring the use of nanoparticles to improve drug solubility and stability. By addressing the limitations of current methods, the research aims to create more effective oral medications that can be better absorbed by the body. Patients may benefit from improved formulations that lead to better therapeutic outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients who require treatment with water-insoluble drugs, such as those with fungal infections or other conditions needing specific medications.
Not a fit: Patients who are not prescribed water-insoluble drugs or those who do not require oral medication may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective oral medications for patients with conditions requiring water-insoluble drugs.
How similar studies have performed: While lipid-based drug delivery systems have been established, this research aims to explore novel approaches that have not yet been tested, making it a potentially groundbreaking effort.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Dong, Xiaowei — University of North Texas Hlth Sci Ctr
- Study coordinator: Dong, Xiaowei
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.